PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133 | -39.8% | 15,913 | -4.0% | 0.00% | – |
| Q2 2023 | $221 | +15.1% | 16,580 | 0.0% | 0.00% | – |
| Q1 2023 | $192 | +40.1% | 16,580 | -1.1% | 0.00% | – |
| Q4 2022 | $137 | -99.9% | 16,765 | -53.4% | 0.00% | -100.0% |
| Q3 2022 | $208,000 | +12.4% | 35,968 | -14.4% | 0.00% | – |
| Q2 2022 | $185,000 | -57.5% | 42,008 | -12.2% | 0.00% | -100.0% |
| Q1 2022 | $435,000 | -57.4% | 47,836 | -4.2% | 0.00% | -50.0% |
| Q4 2021 | $1,021,000 | +94.1% | 49,941 | +142.4% | 0.00% | +100.0% |
| Q3 2021 | $526,000 | -10.8% | 20,603 | +22.0% | 0.00% | 0.0% |
| Q2 2021 | $590,000 | +10.1% | 16,882 | +4.9% | 0.00% | -50.0% |
| Q1 2021 | $536,000 | +95.6% | 16,094 | +52.3% | 0.00% | +100.0% |
| Q4 2020 | $274,000 | – | 10,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |